Ally Bridge Starts Hedge Fund for Listed China Healthcare Companies

Ally Bridge Group, a Hong Kong-US investment firm, has opened a new fund that invests in listed China life science companies, including those on both the mainland and the Hong Kong exchanges. The fund, called the Ally Bridge LB Healthcare Fund, began operations on July 15, according to a Bloomberg report. It is described as a hedge fund, implying the fund intends to sell short overvalued companies while buying shares in attractively priced entities. Frank Yu, the founder and CEO of Ally Bridge, did not disclose how much money was raised for the fund. More details.... Share this with colleagues: // //